LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Search

Arrowhead Pharmaceuticals Inc

Closed

SectorHealthcare

74.12 4.62

Overview

Share price change

24h

Current

Min

69.97

Max

75.08

Key metrics

By Trading Economics

Income

-161M

-133M

Sales

-190M

74M

P/E

Sector Avg

47.744

49.052

EPS

-0.93

Profit margin

-180.007

Employees

711

EBITDA

-165M

-107M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+26.18% upside

Dividends

By Acuity

Next Earnings

6 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-293M

10B

Previous open

69.5

Previous close

74.12

News Sentiment

By Acuity

50%

50%

154 / 344 Healthcare

Arrowhead Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

10 Jun 2026, 23:53 UTC

News
Correlated Moves

Silver/GBP declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also trades lower.

10 Jun 2026, 23:52 UTC

News
Correlated Moves

SPDR Gold Shares are trading lower after reports of explosions in Tehran raise regional stability concerns, prompting investors to seek safe-haven assets.

10 Jun 2026, 23:52 UTC

News
Correlated Moves

Silver/JPY is trading lower as geopolitical tensions in Iran affect investor sentiment and contribute to fluctuations in precious metals. Gold's decline also impacts silver prices.

10 Jun 2026, 23:52 UTC

News
Correlated Moves

Silver prices are lower amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes.

10 Jun 2026, 23:52 UTC

News
Correlated Moves

Silver/CAD declines amid geopolitical tensions in Iran and rising U.S. inflation, reversing a trend of higher daily closes. Gold also trades lower in correlation.

10 Jun 2026, 23:52 UTC

News
Correlated Moves

Silver declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also shows a downward movement.

10 Jun 2026, 23:51 UTC

News
ETF Constituents

The Vanguard Growth ETF is lower in after-market hours, impacted by declines in major holdings like Amazon and AMD amid broader geopolitical tensions.

10 Jun 2026, 23:46 UTC

News

Starbucks Corp reported strong Q2 results and positive FY26 guidance. Shares are modestly higher in after-market trading, recovering from an earlier dip.

10 Jun 2026, 23:44 UTC

News
Social Media
ETF Constituents
Correlated Moves

Invesco QQQ Trust trades lower in after-market hours amid rising geopolitical tensions and inflation concerns, reflecting declines in major holdings like AMD.

10 Jun 2026, 23:42 UTC

News
Social Media

Tesla Inc shares are lower in after-market hours amid broader market declines. The company has started delivering its Cybertruck variant priced at $59,990.

10 Jun 2026, 23:41 UTC

Macro News
News
ETF Constituents
Correlated Moves

Vanguard Information Technology ETF is lower in after-market hours amid declining tech stocks and rising geopolitical tensions between the U.S. and Iran.

10 Jun 2026, 23:41 UTC

News
Correlated Moves
Social Media

AMD declines in after-market trading amid AI demand concerns.

10 Jun 2026, 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market hours amid a broader market decline and ongoing pressures in the semiconductor sector.

10 Jun 2026, 23:31 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is lower in after-market hours, following CPI data that raised inflation concerns and speculation on Federal Reserve policies.

10 Jun 2026, 23:31 UTC

News
Correlated Moves

Intel Corp shares are lower in after-market hours amid broader market declines and ongoing geopolitical tensions affecting investor sentiment in the semiconductor sector.

10 Jun 2026, 23:31 UTC

News
ETF Constituents
Correlated Moves

The iShares Russell 2000 ETF is trading lower in after-market hours, following a decline in the Russell 2000 Index amid inflation concerns.

10 Jun 2026, 23:22 UTC

News
Social Media
Correlated Moves
ETF Constituents

SPDR S&P 500 ETF Trust declines in after-market trading amid broader market weakness. Concerns rise as SPY breaks below $724 and geopolitical tensions persist.

10 Jun 2026, 23:21 UTC

News

iShares Silver Trust declines in after-market hours amid geopolitical tensions and rising U.S. inflation, breaking a recent trend of higher daily closes.

10 Jun 2026, 23:12 UTC

News
Social Media
Correlated Moves

Meta Platforms is lower in after-market hours amid a broader market decline. The company is building a data center in Gujarat, India.

10 Jun 2026, 23:11 UTC

News

Silver is trading higher during Wednesday's session, influenced by geopolitical tensions in Iran that may affect regional stability and global supply chains.

10 Jun 2026, 23:06 UTC

News
Correlated Moves
Macro Event

Ethereum is trading lower amid rising inflation concerns and geopolitical tensions. The asset's decline aligns with Bitcoin's recent drop in market sentiment.

10 Jun 2026, 23:03 UTC

News
Correlated Moves
Social Media

Microsoft shares are lower in after-market hours amid reports of significant layoffs in its Xbox division as part of a restructuring effort.

10 Jun 2026, 23:02 UTC

News

United States Oil Fund LP gains in after-market trading amid military strikes on Iran, reflecting heightened geopolitical tensions and their impact on crude oil sentiment.

10 Jun 2026, 23:02 UTC

News
ETF Constituents
Social Media
Correlated Moves

U.S. stock indices fell in after-market hours, driven by rising energy costs and inflation concerns. The SPDR Dow Jones Industrial Average ETF Trust declined alongside key holdings.

10 Jun 2026, 21:02 UTC

News

Incyte shares rise in after-market trading on Guggenheim target increase.

10 Jun 2026, 20:07 UTC

News
Correlated Moves

USD/NOK declines as May budget deficit of -$293 billion exceeds expectations. The pair briefly rebounded earlier but has since fallen during the session.

10 Jun 2026, 20:07 UTC

News
Correlated Moves

The U.S. federal budget deficit for May was -$293 billion, surpassing expectations. USD/PLN is trading higher, reflecting a cumulative increase since Tuesday.

10 Jun 2026, 20:07 UTC

Correlated Moves
News
Macro Event

The U.S. federal budget deficit for May reached -$293 billion, exceeding forecasts. The USD/SEK exchange rate is advancing amid persistent inflationary pressures.

10 Jun 2026, 20:07 UTC

News
Correlated Moves

U.S. federal budget deficit for May reached -$293 billion, larger than expected. USD/SGD trading roughly flat amid this macro backdrop.

10 Jun 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The U.S. budget deficit for May reached $293 billion, surpassing forecasts. The USD/CZK exchange rate is trading higher amid mortgage rate volatility.

Peer Comparison

Price change

Arrowhead Pharmaceuticals Inc Forecast

Price Target

By TipRanks

26.18% upside

12 Months Forecast

Average 89.25 USD  26.18%

High 110 USD

Low 46 USD

Based on 10 Wall Street analysts offering 12 month price targets forArrowhead Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

8

Buy

2

Hold

0

Sell

Sentiment

By Acuity

154 / 344 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.
help-icon Live chat